RARA CRAFT DATABASE for FDA Medical Devices
510(k)K261856

FDA DEVICE FACTS

Halcyon, Ethos Radiotherapy System (5.0)

Varian Medical Systems, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEAugust 3, 2026PRODUCT CODEIYE

Indications for use

Halcyon and Ethos radiotherapy system are indicated for the delivery of stereotactic radiosurgery and precision radiotherapy for lesions, tumors, and conditions anywhere in the body where radiation is indicated for adults and pediatric patients. Halcyon and Ethos radiotherapy system with the HyperSight imaging feature produce kV CBCT anatomical images that can be used in the simulation and planning of radiation therapy.

The Halcyon and Ethos Radiotherapy systems may be used in the delivery of radiation treatment for adults with the following non-cancerous medically refractory hyperproliferative disorders: Dupuytren's contracture, Ledderhose disease, heterotopic ossification, and keloids; and low dose radiotherapy for adults with non-cancerous medically refractory osteoarthritis; and the following periarticular soft tissue disorders: plantar fasciitis, shoulder syndrome, trochanteric bursitis, and tennis/golf elbow.

The modification to the Indications for use does not change the Intended Use of the device, as the general purpose of the device and its function remain the same. Additionally, the intended therapeutic use of the device remains the same - "to provide stereotactic radiosurgery and precision radiotherapy for lesions, tumors, and conditions anywhere in the body where radiation treatment is indicated." As demonstrated by the risk management activities per ISO 14971, the differences do not affect the safety and effectiveness of the device when used as labeled.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 11, 2026